Picture of Humacyte logo

HUMA — Humacyte News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: FDA Approves First Acellular Tissue Engineered Vessel To Treat Vascular Trauma In Extremities

Dec 20 (Reuters) - FDA:
    * FDA APPROVES FIRST ACELLULAR TISSUE ENGINEERED VESSEL TO
TREAT
VASCULAR TRAUMA IN EXTREMITIES
    * FDA: GRANTED APPROVAL OF SYMVESS TO HUMACYTE GLOBAL INC

Further company coverage:  HUMA.O 

 (((( Reuters.Briefs@thomsonreuters.com ;));))

Recent news on Humacyte

See all news